Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Macular Edema Incidence/Severity Reduction With Nevanac

Authors not listed

Alcon Research · 2009

Abstract

The purpose of this study is to evaluate NEVANAC in patients with diabetic retinopathy who developed macular edema (ME) within 90 days following cataract surgery.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-15 MST

Cite this

APA
Anonymous. (2009). Macular Edema Incidence/Severity Reduction With Nevanac. <em>Alcon Research</em>. https://clinicaltrials.gov/study/NCT00939276
Vancouver
Anonymous. Macular Edema Incidence/Severity Reduction With Nevanac. Alcon Research. 2009.
BibTeX
@misc{anon2009Macula, title = {Macular Edema Incidence/Severity Reduction With Nevanac}, author = {Anonymous}, journal = {Alcon Research}, year = {2009}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings